[Protracted recurrent neuroleptic malignant syndrome]

Rev Neurol (Paris). 1990;146(8-9):515-7.
[Article in French]

Abstract

The natural course of untreated neuroleptic malignant syndrome (NMS) does not usually exceed 3 weeks. Its duration is reduced by dantrolene and/or bromocriptine. We report a patient in whom NMS developed after an injection of haloperidol decanoate and fluctuated during 3 months. This was due perhaps because the initial treatment with oral neuroleptic was pursued, or because the doses of dantrolene were insufficient.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Bromocriptine / therapeutic use
  • Dantrolene / administration & dosage
  • Dantrolene / therapeutic use*
  • Dose-Response Relationship, Drug
  • Female
  • Haloperidol / adverse effects
  • Humans
  • Neuroleptic Malignant Syndrome / drug therapy
  • Neuroleptic Malignant Syndrome / physiopathology*
  • Recurrence

Substances

  • Bromocriptine
  • Dantrolene
  • Haloperidol